Skip to content

Clinical trials

Phase 3 trials in Morocco

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Country / region: Morocco Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20053
20063
20074
20086
20094
20101
20111
20123
20132
20144
20151
20172
20182
20191
20202
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated4
Active, not recruiting3
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche13
Sanofi8
International Atomic Energy Agency3
Novo Nordisk A/S3
International Breast Cancer Research Foundation2
Merck KGaA, Darmstadt, Germany2
Novartis Pharmaceuticals2
Vanda Pharmaceuticals2
AstraZeneca1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms9
Diabetes Mellitus, Type 24
Atrial Fibrillation3
Hypertension3
Multiple Sclerosis3
Acute Coronary Syndrome2
Arthritis, Rheumatoid2
Carcinoma, Non-Small-Cell Lung2
Diabetes Mellitus2
Lung Neoplasms2

Trials

Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.